Alice Ly

Part of Alexandria Real Estate Equities, Inc., Alexandria Launchlabs is a full-service startup platform that accelerates the growth of early-stage life science and agtech companies. The American company provides move-in-ready office/laboratory space, support resources, shared equipment and services, creative amenities, and access to startup capital through the Alexandria Seed Capital Platform. The company has implemented comprehensive COVID-19 operational measures to ensure the safety and well-being of their member companies. Alexandria Launchlabs is currently accepting applications for future members in various locations.

Alexandria Venture Investments LLC (Alexandria Venture) is a venture capital subsidiary of Alexandria Real Estate Equities, Inc. founded in 1996 by Joel S. Marcus. The firm is headquartered in Pasadena, California.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA.

Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA.

ApoGen Biotechnologies, Inc. operates as a biotechnology firm, which focuses on the development of therapeutics targeting drivers of cancer genomic mutation. The company was founded by John T. Santini, Jr., Reuben S. Harris, and Daniel A. Harki in 2014 and is headquartered in Seattle, WA.

Rodeo Therapeutics Corp. engages in the development of drugs. The firm develops novel small molecules therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant. It focuses on the development of small-molecule therapies that increase tissue levels of prostaglandin PGE2. The company was founded by Stanton Gerson, Sanford Markowitz, and Joseph Ready on May 15, 2017 and is headquartered in Seattle, WA.

Part of Harvard University, Harvard Innovation Labs is an alternative investment manager. The company is based in Cambridge, MA and was founded in 2011.